Search results

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Health researchers have developed a new method for producing PET radiotracers.

A desire to give people around the world greater access to the benefits of nuclear medicine is behind Robert Raposio and his research into producing radioisotopes in more efficient, cheaper and sustainable ways.

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.

The final report on the safety of Building 23 by the independent expert review team has been completed.

Using the past to illuminate the future: Brothers collaborate on important science documentary for ABC TV

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

Latest information on the scheduled supply of our nuclear medicine production.